At Nusbaum Medical Centers, we utilize specific monitoring protocols to catch early warning signs, ensuring your journey remains safe and controlled
Available online at: (accessed July 29, 2022)
difficulty breathing or swallowing) Changes in vision Signs of kidney problems (changes in urination) Signs of gallbladder problems Additional Contraindications According to prescribing information, semaglutide should be used with caution or avoided in patients with history of pancreatitis, severe gastrointestinal disease, or diabetic retinopathy
For Naples residents seeking effective options for weight loss, these treatments represent a new and exciting era
Tirzepatide (Mounjaro, Zepbound) is a once-weekly subcutaneous injection approved by the FDA for type 2 diabetes management and chronic weight management
You'll receive clear instructions on how to take it, and your care doesn't stop there